Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.
2.

Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.

Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.

Curr Med Res Opin. 2011 Jan;27(1):87-98. doi: 10.1185/03007995.2010.537317. Epub 2010 Nov 24.

PMID:
21091391
3.

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.

Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N.

Clin Interv Aging. 2014 Jun 18;9:947-61. doi: 10.2147/CIA.S65625. eCollection 2014.

4.

Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.

Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.

Curr Med Res Opin. 2007 Oct;23(10):2597-605.

PMID:
17875243
5.

The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.

Luthringer R, Muzet M, Zisapel N, Staner L.

Int Clin Psychopharmacol. 2009 Sep;24(5):239-49. doi: 10.1097/YIC.0b013e32832e9b08.

PMID:
19584739
6.

Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials.

Lemoine P, Wade AG, Katz A, Nir T, Zisapel N.

Integr Blood Press Control. 2012;5:9-17. doi: 10.2147/IBPC.S27240. Epub 2012 Jan 25.

7.

Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial.

Roth T, Nir T, Zisapel N.

Nat Sci Sleep. 2015 Jan 29;7:13-23. doi: 10.2147/NSS.S71838. eCollection 2015.

8.

Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.

Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N.

Ther Clin Risk Manag. 2011;7:301-11. doi: 10.2147/TCRM.S23036. Epub 2011 Jul 26.

10.
11.

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.

Sleep. 2010 Nov;33(11):1553-61.

12.

Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.

Dolev Z.

Arch Womens Ment Health. 2011 Jun;14(3):269-73. doi: 10.1007/s00737-011-0205-7. Epub 2011 Feb 12.

PMID:
21311927
13.

Improvement of sleep quality in elderly people by controlled-release melatonin.

Garfinkel D, Laudon M, Nof D, Zisapel N.

Lancet. 1995 Aug 26;346(8974):541-4.

PMID:
7658780
14.

Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin.

Hajak G, Lemme K, Zisapel N.

Int Clin Psychopharmacol. 2015 Jan;30(1):36-42. doi: 10.1097/YIC.0000000000000046.

15.

Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.

Sleep. 2009 Mar;32(3):351-60.

16.

The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.

Zemlan FP, Mulchahey JJ, Scharf MB, Mayleben DW, Rosenberg R, Lankford A.

J Clin Psychiatry. 2005 Mar;66(3):384-90.

PMID:
15766306
17.

Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.

Lyseng-Williamson KA.

Drugs Aging. 2012 Nov;29(11):911-23. doi: 10.1007/s40266-012-0018-z. Review.

PMID:
23044640
19.

Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.

Lankford A, Rogowski R, Essink B, Ludington E, Heith Durrence H, Roth T.

Sleep Med. 2012 Feb;13(2):133-8. doi: 10.1016/j.sleep.2011.09.006. Epub 2011 Dec 24.

PMID:
22197474
20.

Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia.

Lemoine P, Zisapel N.

Expert Opin Pharmacother. 2012 Apr;13(6):895-905. doi: 10.1517/14656566.2012.667076. Epub 2012 Mar 19. Review.

PMID:
22429105

Supplemental Content

Support Center